Review



human cd200 percp conjugated antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems human cd200 percp conjugated antibody
    Expression of CD160 and <t> CD200 </t> on B lymphocytes of healthy subjects and on leukemic cell clone of the patients
    Human Cd200 Percp Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 10 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd200+percp+conjugated+antibody/Human+CD200+APC-conjugated+Antibody/pmc07167601-120-9-16
    Average 93 stars, based on 10 article reviews
    human cd200 percp conjugated antibody - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms"

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    doi:

    Expression of CD160 and  CD200  on B lymphocytes of healthy subjects and on leukemic cell clone of the patients
    Figure Legend Snippet: Expression of CD160 and CD200 on B lymphocytes of healthy subjects and on leukemic cell clone of the patients

    Techniques Used: Expressing, Control

    CD200 expression on different B-cell neoplasms and the control group
    Figure Legend Snippet: CD200 expression on different B-cell neoplasms and the control group

    Techniques Used: Expressing, Control

    ROC curves of CD160 and CD200 for diagnosing CLL from the other MBN
    Figure Legend Snippet: ROC curves of CD160 and CD200 for diagnosing CLL from the other MBN

    Techniques Used:

    ROC curves for combined expression of CD160 & CD200 to diagnose CLL cases from the MBN.
    Figure Legend Snippet: ROC curves for combined expression of CD160 & CD200 to diagnose CLL cases from the MBN.

    Techniques Used: Expressing

    Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 percentage expression.
    Figure Legend Snippet: Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 percentage expression.

    Techniques Used: Control, Expressing

    Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 MFIR.
    Figure Legend Snippet: Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 MFIR.

    Techniques Used: Control

    Related Articles

    Expressing:

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms
    Article Snippet: All cases included in the study were subjected to full history taking ,thorough clinical examination and laboratory investigations including complete blood count in K2 EDTA tubes analyzed by automated cell counter ADVIA 2120 hematology system (Siemens Healthcare Diagnostics, serial number 10285573,Eschborn, Germany) and immunophenotyping for diagnosis using chronic flow cytometry panel adopted in our department including (CD5 FITC, clone UCHT2, cat no 555352, CD19PE, clone HIB19, cat no 555413,CD22 FITC clone HIB22, cat no 555424, FMC7 FITC, clone FMC7, cat no 332786, Kappa FITC, clone G20-193, cat no 555791, Lambda PE, clone JDC-12, cat no 555797,CD10PE, clone HI10a, cat no 555375 from BD Biosciences, USA&CD23 FITC-conjugated antibody, clone 9p25, cat no PN A07409; Beckman, USA) done for patients only using Becton Dickinson, FACS4-colors Calibur flow cytometer equipped with BD CellQuest Pro software (BD biosciences, San Jose, CA, USA).no 555791, Lambda PE, clone JDC-12, cat no 555797,CD10PE, clone HI10a, cat no 555375 from BD Biosciences, USA&CD23 FITC-conjugated antibody, clone 9p25, cat no PN A07409; Beckman, USA) done for patients only using Becton Dickinson, FACS4-colors Calibur flow cytometer equipped with BD CellQuest Pro software (BD biosciences, San Jose, CA, USA). ... In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.. Peripheral blood cells were processed for investigation of CD160 and CD200 expression using a combination of CD19, CD160, CD200 and CD5.Peripheral blood cells were processed for investigation of CD160 and CD200 expression using a combination of CD19, CD160, CD200 and CD5.

    Control:

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms
    Article Snippet: All cases included in the study were subjected to full history taking ,thorough clinical examination and laboratory investigations including complete blood count in K2 EDTA tubes analyzed by automated cell counter ADVIA 2120 hematology system (Siemens Healthcare Diagnostics, serial number 10285573,Eschborn, Germany) and immunophenotyping for diagnosis using chronic flow cytometry panel adopted in our department including (CD5 FITC, clone UCHT2, cat no 555352, CD19PE, clone HIB19, cat no 555413,CD22 FITC clone HIB22, cat no 555424, FMC7 FITC, clone FMC7, cat no 332786, Kappa FITC, clone G20-193, cat no 555791, Lambda PE, clone JDC-12, cat no 555797,CD10PE, clone HI10a, cat no 555375 from BD Biosciences, USA&CD23 FITC-conjugated antibody, clone 9p25, cat no PN A07409; Beckman, USA) done for patients only using Becton Dickinson, FACS4-colors Calibur flow cytometer equipped with BD CellQuest Pro software (BD biosciences, San Jose, CA, USA).no 555791, Lambda PE, clone JDC-12, cat no 555797,CD10PE, clone HI10a, cat no 555375 from BD Biosciences, USA&CD23 FITC-conjugated antibody, clone 9p25, cat no PN A07409; Beckman, USA) done for patients only using Becton Dickinson, FACS4-colors Calibur flow cytometer equipped with BD CellQuest Pro software (BD biosciences, San Jose, CA, USA). ... In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.. Peripheral blood cells were processed for investigation of CD160 and CD200 expression using a combination of CD19, CD160, CD200 and CD5.Peripheral blood cells were processed for investigation of CD160 and CD200 expression using a combination of CD19, CD160, CD200 and CD5.



    Similar Products

    93
    R&D Systems human cd200 percp conjugated antibody
    Expression of CD160 and <t> CD200 </t> on B lymphocytes of healthy subjects and on leukemic cell clone of the patients
    Human Cd200 Percp Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd200+percp+conjugated+antibody/Human+CD200+APC-conjugated+Antibody/pmc07167601-120-9-16
    Average 93 stars, based on 1 article reviews
    human cd200 percp conjugated antibody - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Expression of CD160 and  CD200  on B lymphocytes of healthy subjects and on leukemic cell clone of the patients

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: Expression of CD160 and CD200 on B lymphocytes of healthy subjects and on leukemic cell clone of the patients

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques: Expressing, Control

    CD200 expression on different B-cell neoplasms and the control group

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: CD200 expression on different B-cell neoplasms and the control group

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques: Expressing, Control

    ROC curves of CD160 and CD200 for diagnosing CLL from the other MBN

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: ROC curves of CD160 and CD200 for diagnosing CLL from the other MBN

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques:

    ROC curves for combined expression of CD160 & CD200 to diagnose CLL cases from the MBN.

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: ROC curves for combined expression of CD160 & CD200 to diagnose CLL cases from the MBN.

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques: Expressing

    Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 percentage expression.

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 percentage expression.

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques: Control, Expressing

    Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 MFIR.

    Journal: International Journal of Hematology-Oncology and Stem Cell Research

    Article Title: Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms

    doi:

    Figure Lengend Snippet: Distribution of patients (CLL and other MBN) and control according to CD 160 and CD200 MFIR.

    Article Snippet: In addition Human CD160 APC-conjugated Antibody, clone 688327 and Human CD200 percp-conjugated Antibody, clone 325516 from R&D systems- Biotechne, USA were added to our panel and analyzed for both patients and controls.

    Techniques: Control